22.11.2016 Views

Panacea Biotec Limited Market Business Overview and Analysis, Research and Development, Pipeline Review 2016

Global Markets Direct's, 'Panacea Biotec Limited - Product Pipeline Review - 2016', provides an overview of the Panacea Biotec Limited's pharmaceutical research and development focus.

Global Markets Direct's, 'Panacea Biotec Limited - Product Pipeline Review - 2016', provides an overview of the Panacea Biotec Limited's pharmaceutical research and development focus.

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

- The report assesses <strong>Panacea</strong> <strong>Biotec</strong> <strong>Limited</strong>'s pipeline therapeutics based on drug target, mechanism of action<br />

(MoA), route of administration (RoA) <strong>and</strong> molecule type<br />

- The report features <strong>Panacea</strong> <strong>Biotec</strong> <strong>Limited</strong>'s out-licensed <strong>and</strong> partnered product portfolio <strong>and</strong> summarizes its<br />

dormant <strong>and</strong> discontinued projects<br />

Reasons To Buy<br />

- Evaluate <strong>Panacea</strong> <strong>Biotec</strong> <strong>Limited</strong>'s strategic position with total access to detailed information on its product<br />

pipeline<br />

- Gain strategically significant competitor information, analysis, <strong>and</strong> insights to formulate effective R&D strategies<br />

- Identify emerging players with potentially strong product portfolio <strong>and</strong> create effective counter-strategies to gain<br />

competitive advantage<br />

- Identify <strong>and</strong> underst<strong>and</strong> important <strong>and</strong> diverse types of therapeutics under development for <strong>Panacea</strong> <strong>Biotec</strong><br />

<strong>Limited</strong><br />

- Identify potential new clients or partners in the target demographic<br />

- Plan mergers <strong>and</strong> acquisitions effectively by identifying key players <strong>and</strong> it's most promising pipeline therapeutics<br />

- Devise corrective measures for pipeline projects by underst<strong>and</strong>ing <strong>Panacea</strong> <strong>Biotec</strong> <strong>Limited</strong>'s pipeline depth <strong>and</strong><br />

focus of pipeline therapeutics<br />

- Develop <strong>and</strong> design in-licensing <strong>and</strong> out-licensing strategies by identifying prospective partners with the most<br />

attractive projects to enhance <strong>and</strong> exp<strong>and</strong> business potential <strong>and</strong> scope<br />

Buy a Sample copy of This Report @ http://www.radiantinsights.com/research/panacea-biotec-limited-productpipeline-review-<strong>2016</strong>/request-sample<br />

Table of Contents<br />

Table of Contents 2<br />

List of Tables 5<br />

List of Figures 6<br />

<strong>Panacea</strong> <strong>Biotec</strong> <strong>Limited</strong> Snapshot 7<br />

<strong>Panacea</strong> <strong>Biotec</strong> <strong>Limited</strong> <strong>Overview</strong> 7<br />

Key Information 7<br />

Key Facts 7<br />

<strong>Panacea</strong> <strong>Biotec</strong> <strong>Limited</strong> - <strong>Research</strong> <strong>and</strong> <strong>Development</strong> <strong>Overview</strong> 8<br />

Key Therapeutic Areas 8<br />

<strong>Panacea</strong> <strong>Biotec</strong> <strong>Limited</strong> - <strong>Pipeline</strong> <strong>Review</strong> 12<br />

<strong>Pipeline</strong> Products by Stage of <strong>Development</strong> 12<br />

<strong>Pipeline</strong> Products - Monotherapy 13<br />

<strong>Pipeline</strong> Products - Combination Treatment Modalities 14<br />

<strong>Panacea</strong> <strong>Biotec</strong> <strong>Limited</strong> - <strong>Pipeline</strong> Products Glance 15<br />

<strong>Panacea</strong> <strong>Biotec</strong> <strong>Limited</strong> - Late Stage <strong>Pipeline</strong> Products 15<br />

Phase III Products/Combination Treatment Modalities 15<br />

<strong>Panacea</strong> <strong>Biotec</strong> <strong>Limited</strong> - Clinical Stage <strong>Pipeline</strong> Products 16<br />

Phase II Products/Combination Treatment Modalities 16<br />

Phase I Products/Combination Treatment Modalities 17<br />

<strong>Panacea</strong> <strong>Biotec</strong> <strong>Limited</strong> - Early Stage <strong>Pipeline</strong> Products 18<br />

Preclinical Products/Combination Treatment Modalities 18<br />

Discovery Products/Combination Treatment Modalities 19<br />

<strong>Panacea</strong> <strong>Biotec</strong> <strong>Limited</strong> - Unknown Stage <strong>Pipeline</strong> Products 20<br />

Unknown Products/Combination Treatment Modalities 20<br />

Access Full Report with TOC @ http://www.radiantinsights.com/research/panacea-biotec-limited-productpipeline-review-<strong>2016</strong>

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!